Atripla
Active substances: Efivarenz + Emtricitabine + Tenofovir
Manufacturer: Bristol-Myers Squibb (UK)
Extract from the prescribing information:
"ATRIPLA is not a cure for HIV infection and patients may continue to experience illnesses associated with HIV infection, including opportunistic infections. Patients should remain under the care of a physician when using ATRIPLA."
The above has been extracted from the Atripla prescribing information on the Bristol-Myers Squibb webpages.